Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD
Devaraj Ezhilarasan
Topics & Concepts
LipotoxicityInsulin resistanceAdipose tissueCD36Fatty liverInternal medicinePeroxisome proliferator-activated receptorEndocrinologyChemistryBiologyInsulinMedicineReceptorDiseaseLiver Disease Diagnosis and TreatmentPeroxisome Proliferator-Activated ReceptorsMetabolism, Diabetes, and Cancer